News from jazz pharmaceuticals plc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:JAZZ)

Feb 01, 2016, 09:05 ET
Jazz Pharmaceuticals Logo

Results from Phase 3 Trial of Defibrotide for the Treatment of Severe Veno-Occlusive Disease and Multi-Organ Failure Published Online in BLOOD

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that data from the phase 3 pivotal study...

Jan 04, 2016, 16:05 ET
Jazz Pharmaceuticals Logo

Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 11

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the 34th Annual J.P....

Nov 04, 2015, 16:05 ET
Jazz Pharmaceuticals Logo

Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at three upcoming investor...

Oct 26, 2015, 16:05 ET
Jazz Pharmaceuticals Logo

Jazz Pharmaceuticals to Report 2015 Third Quarter Financial Results on November 9, 2015

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2015 third quarter financial results on Monday, November 9, 2015,...

Sep 30, 2015, 08:30 ET
Jazz Pharmaceuticals Logo

Jazz Pharmaceuticals Announces U.S. FDA Acceptance for Filing with Priority Review of NDA for Defibrotide for Hepatic Veno-Occlusive Disease

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted for...

Aug 05, 2015, 16:05 ET

Jazz Pharmaceuticals Announces Second Quarter 2015 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the second quarter of 2015 and reaffirmed financial guidance for...

Jul 22, 2015, 16:05 ET

Jazz Pharmaceuticals to Report 2015 Second Quarter Financial Results on August 5, 2015

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2015 second quarter financial results on Wednesday, August 5,...

Jul 01, 2015, 16:05 ET

Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the Cantor Fitzgerald...

Jun 08, 2015, 09:05 ET
Jun 04, 2015, 09:05 ET

Jazz Pharmaceuticals to Present Abstracts from Ongoing Evaluations of Xyrem® (sodium oxybate) at SLEEP 2015

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will present abstracts related to the ongoing clinical evaluation of Xyrem® (sodium oxybate)...

May 15, 2015, 16:05 ET

Jazz Pharmaceuticals Announces Participation in Two Investor Conferences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming investor...

May 07, 2015, 16:05 ET

Jazz Pharmaceuticals Announces First Quarter 2015 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter ended March 31, 2015 and reaffirmed...

Apr 23, 2015, 16:05 ET

Jazz Pharmaceuticals to Report 2015 First Quarter Financial Results on May 7, 2015

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2015 first quarter financial results on Thursday, May 7,...

Feb 24, 2015, 16:05 ET

Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2014 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and the fourth quarter ended December 31, 2014 and...

Feb 23, 2015, 16:05 ET

Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming investor...

Feb 12, 2015, 08:30 ET

Jazz Pharmaceuticals to Present Data on Defibrotide, an Investigational Treatment, in Patients with Hepatic Veno-Occlusive Disease (VOD) at BMT Tandem Meetings

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that researchers will present data on the use of defibrotide, an investigational...

Feb 10, 2015, 16:05 ET

Jazz Pharmaceuticals to Report 2014 Fourth Quarter and Full Year Financial Results on February 24, 2015

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2014 fourth quarter and full year financial results on Tuesday,...

Jan 05, 2015, 16:05 ET

Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 12

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the 33rd Annual J.P....

Dec 19, 2014, 19:05 ET

Jazz Pharmaceuticals Receives FDA Approval For Intravenous Administration Of Erwinaze® (asparaginase Erwinia chrysanthemi)

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved the intravenous...

Dec 11, 2014, 16:05 ET

Jazz Pharmaceuticals Initiates Rolling NDA Submission For Defibrotide For The Treatment Of Severe Hepatic Veno-Occlusive Disease

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the initiation of a rolling submission of a New Drug Application (NDA) to the United...